The parenteral administration of potent analgesic agents, most commonly of the narcotic group, remains the principal form of treatment for postoperative pain. However, narcotic analgesics may produce undesirable side effects: drowsiness, emesis and respiratory depression. Moreover, their use is subject to legislative restrictions. Hitherto, the availability of parenteral preparations of non-narcotic analgesics has been limited. However, it has been suggested that a parenteral salicylate preparation, lysine acetyl salicylate (LAS), in a dose of 1.8 g (equivalent to acetyl salicylate 1 g), can provide analgesia equivalent to that provided by morphine 10 mg (Kweekel-De Vries et al., 1974). This study reports on a comparison of the analgesic effect of a continuous i.v. infusion of LAS with that of morphine (administered similarly) for the relief of pain following thoracotomy.
PATIENTS AND METHODS
The study was approved by the hospital ethics committee and 22 patients gave written informed consent. All patients were ASA class II/III, aged between 28 yr and 77 yr and scheduled to undergo a standard thoracotomy for pulmonary surgery. The patients were randomly allocated to two groups to receive either LAS or morphine. The trial was conducted double-blind and one of the authors (JC) carried out all of the pain assessments using a simple verbal 5-point scoring system (none = 0; mild = 1; moderate = 2; severe = 3 ; very severe = 4). Bleeding times and platelet counts were estimated before operation in all patients. Patients with a known intolerance to salicylates, with an abnormal bleeding tendency or prolonged bleeding time, or with a history of peptic ulceration were excluded from the trial. Patients were premedicated with diazepam 10 mg by mouth and atropine 0.6 mg i.m. Anaesthesia was induced with thiopentone 4 mg kg" 1 and pancuronium 0.07 mg kg" 1 was administered to facilitate endobronchial intubation. Anaesthesia was maintained with nitrous oxide in oxygen supplemented with 0.5-1.0% halothane. Intercostal blockade was not performed, nor was cryotherapy used. All of the operations were performed by the same surgeon.
At the termination of surgery all patients received a single injection of papaveretum 10 mg i.m.; residual neuromuscular blockade was antagonized with neostigmine 2.5 mg (plus atropine 1.2 mg) and the patient was returned to the recovery area when the anaesthetist was satisfied with the patient's haemodynamic and respiratory status. After surgery, assessments of the severity of the pain were made by one single-blinded observer. The initial pain assessment was not made until the patient had recovered sufficiently from the anaesthetic to com-municate a verbal pain score. Following the initial assessment of pain in the recovery area, patients were allocated randomly to receive either morphine 10 mg or LAS 1.8 g administered i.v. over 5 min. Pain assessments were then made 30 min and 1 h after the initial dose of the trial drug. After the latter assessment a 24-h i.v. infusion administering a total dose of either morphine 40 mg or LAS 7.2 g was commenced. Subsequent assessments were made after the infusion had been in progress for 3 and 18 h, and on completion of the infusion, at which time the patients were asked for an overall assessment of pain.
During the 24-h infusion, patients were able to self-administer a preset incremental dose of papaveretum 0.5 mg i.v., delivered over 1 min, from an automatic patient-controlled analgesic (PCA) device, with the lockout time set at 60 min (Cardiff Pallia tor). The cumulative dose administered by this device was recorded after 3, 18 and 24 h. Papaveretum 10-15 mg i.m. was prescribed for any patient who required further pain relief. Analogue rating scales were used to assess the possible side effects of drowsiness, nausea and vomiting during the period after operation. A record of respiratory rate was made every 10 min for the first hour, every 15 min for the next hour, every 30 min for the next 2 h, every 60 min for the next 8 h, 2-hourly for the following 8 h and 4-hourly thereafter. An assessment of postoperative bleeding was made by measuring the daily loss recovered via the intercostal drains, for as long as these remained in situ.
Statistical analysis of data
Student's t test (unpaired) was used for betweengroup comparisons of demographic data; pain scores and other non-parametric data were analysed using the Wilcoxon's ranking test for unpaired data. A comparison of the incidence of side effects was made using the Chi-squared test with the Yates' correction factor. Values of P < 0.05 were considered to be statistically significant. All results are reported as mean (standard deviation). There were no significant differences in age, sex distribution, body weight or type and duration of surgery between the two groups (tables I and II). No patient had a preoperative bleeding time of greater than 240 s. Two patients were withdrawn from the trial as a result of violations of procedure, thus 20 patients were studied, 10 who had received morphine and 10 who received LAS. One patient in the LAS group received a small dose of fentanyl (100 |xg) during the operation.
Evaluation of pain
The mean pain scores are outlined in table III. On arrival of the patient in the recovery area, the mean pain scores were 2.70 and 2.45 for the LAS and morphine groups, respectively (ns). The mean pain scores of the two groups did not differ significantly at any time (although initially the scores were slightly lower in the morphine group). The use of patient controlled analgesia (PCA) was not significantly different in the two groups (table IV) . Adjusted to a \ig kg" 1 h" 1 basis, the LAS group selfadministered overall papaveretum 4.4 fig kg" 1 h" 1 and the morphine group 3.7 \ig kg" 1 h" 1 . Additional analgesia i.m. was required by two patients in the LAS group and by three patients in the morphine group. All patients were satisfied with the overall quality of pain relief (overall mean pain scores: LAS 1.60 and morphine 1.80). The mean time from completion of the 24-h infusion to the first subsequent administration of an analgesic was 4.54 (2.60) h in the LAS group and 3.01 (2.09) h in the morphine group (ns). 
Side effects
There were no differences in the incidence of nausea, vomiting or use of anti-emetics between the two groups (table V). Morphine was associated with higher sedation scores throughout (table VI), although this difference was significant only at 1 h. No patient in either group was noted to have a respiratory rate of less than 12 b.p.m. at any stage. The mean daily blood loss collected from the intercostal drains was 251 ml in the LAS group (range 122-491 ml) and 213 ml in the morphine group (range 90-462 ml); this difference was not significant. DISCUSSION Stapleton, Austin and Mather (1979) have suggested that a continuous i.v. infusion of an analgesic agent may offer significant advantages in the provision of pain relief when compared with intermittent i.m. injections. When used in conjunction with a PC A system, this method has the additional advantage of providing an objective comparison of the relative effectiveness of different analgesic drugs. The combination of an "active" PCA system and a "passive" background infusion regimen is particularly effective in treating pain (Welchew, 1983) . In the present study we have demonstrated that a continuous i.v. infusion of LAS 1.8 g over 6 h can provide pain relief similar to that provided by a continuous infusion of morphine 10 mg over 6 h. Although the mean pain scores did not differ significantly throughout the trial period, the earlier pain scores of the patients in the morphine group were slightly lower than those of the patients in the LAS group (but it should be noted that the initial pain scoresobtained before injection of the trial drug in the recovery area-were higher in those patients subsequently receiving LAS). However, the fact that morphine had effected a slight reduction in pain score 30 and 60 min after the initial i.v. bolus, whereas LAS had not, does tend to suggest that LAS is either not quite as effective as morphine in relieving the severe pain immediately following pulmonary surgery, or that its onset of action is slower.
All patients were satisfied with the overall quality of pain relief (there being a slightly lower overall mean pain score in the LAS group), although when questioned after the infusion had been in progress for 3 h, 60% of patients (in both treatment groups) were experiencing moderate or severe pain. Stapleton, Austin and Mather (1979) also reported that more than 60% of patients who had undergone lower abdominal, as opposed to pulmonary surgery, experienced moderate or severe pain during the first 4 h of an infusion of pethidine. This was despite apparently effective blood concentrations which were 50-100% in excess of the suggested therapeutic concentration. These observations suggest that pain experienced early after operation is relatively refractory to effective treatment by drugs (narcotic or otherwise), but that a patient's memory for this early pain is poor. Patient acceptance of the technique was high, with only one patient (in the LAS group) experiencing difficulty in the use of the PC A system. It was especially useful in allowing the full and vigorous physiotherapy which these patients require. The incidence of nausea and vomiting, and the need for anti-emetic drugs, were almost identical in the two groups. This is in contrast to the findings of a previous study in which an infusion of LAS was associated with a lower incidence of these side effects (Cashman et al., 1984) . It would seem that even the small dose of narcotic administered via the PC A system was responsible for a marked increase in these particular side effects. The incidence of drowsiness was greater in the morphine group, and whereas this may be an advantage following other types of major surgery, it is not necessarily so following pulmonary surgery. However, no patient in either group was noted to have a respiratory rate of less than 12 b.p.m.
For the purposes of the present study it was decided to utilize a verbal pain scoring system. This was first described by Keele in 1948 . We believe that the advantages of this system outweigh the disadvantages. Not only does it benefit from being simple and easily understood, but it was anticipated that there might be problems with the use of a visual analogue scale in the period early after operation, when the patients were still under the influence of general anaesthesia. Furthermore, because of the nature of the surgery being performed, patients were expected to experience difficulty in using their dominant arm to mark a visual analogue scale, regardless of the side on which surgery had been performed.
Aspirin is known to influence platelet function and an adverse effect on haemostasis would limit its clinical usefulness as a parenteral analgesic. We have demonstrated that patients receiving an infusion of LAS 7.2 g over 24 h (equivalent to acetyl salicylic acid 4.0 g) do not have a greater blood loss after operation than patients receiving morphine. Acetyl salicylic acid is now known to have a paradoxical effect on the bleeding time as a result of a dosedependent differential action on the platelet aggegating inhibitor, prostacyclin, and the proaggregating thromboxane (O'Grady and Moncada, 1978) . Acute doses of less than 1 g have been shown to prolong bleeding time, whilst larger doses are associated with no prolongation of bleeding time (Rajah, Penny and Kester, 1978) .
We feel that the present study has also demonstrated a novel and effective approach to the relief of pain after operation, namely the use of a continuous infusion of a non-narcotic analgesic coupled with a PCA system administering small incremental doses of a narcotic analgesic. However, it should be emphasized that, as a result of the double-blind randomized nature of the trial, the maximum dose of on-demand analgesia was identical for both treatment groups. Despite the sub-optimal increments that this caused the patients in the LAS group to receive, the pain scores were not appreciably greater in the early period after operation, and were actually lower in the later period. In practice, it is to be anticipated that larger incremental doses or a shorter lock-out time could be used, with obvious advantages for the quality of the analgesia obtained.
In conclusion, an infusion of LAS 1.8g 6-hourly following major thoracic surgery has been shown to provide a quality of pain relief similar to that derived from an infusion of morphine lOmg 6-hourly. The combination of an infusion of a non-narcotic coupled with a Patient Controlled Analgesic system administering small increments of a narcotic analgesic has proved to be a safe and effective method of providing pain relief after major surgery.
